BACKGROUND AND AIMS: Recent data suggest identification of causal genetic variants for inflammatory bowel disease in the DLG5 gene and in the organic cation transporter (OCTN) cluster, both situated in previously described linkage regions. PATIENTS AND METHODS: The polymorphisms in DLG5 (113 G-->A, 4136 C-->A, and DLG5_e26), SLC22A4 (1672 C-->T), and SLC22A5 (-207 G-->C) were assessed in 625 patients with Crohn's disease (CD), 363 patients with ulcerative colitis (UC), and 1012 healthy controls. Association with disease susceptibility, clinical phenotypes, and possible genetic interactions of these polymorphisms with disease associated CARD15/NOD2 mutations was analysed. RESULTS: No significant association of DLG5 polymorphisms with CD or UC was observed. Homozygosity for the OCTN-TC haplotype was associated with an increased CD risk (OR = 1.65), which was even greater in the presence of CARD15 mutations. Genotype-phenotype analysis revealed that this association was particularly strong in patients with colonic disease. The TC haplotype was associated with non-fistulising non-fibrostenotic disease, an earlier age of disease onset, and reduced need for surgery. CONCLUSION: Our observations argue against a role of DLG5 polymorphisms in the susceptibility for inflammatory bowel disease, whereas the OCTN polymorphisms are associated with CD. However, due to the comparable weak association observed herein, extended linkage disequilibrium analyses of these variants with the IBD5 haplotype tagged single nucleotide polymorphims might be advisable before definitive conclusions about their causative role in CD can be drawn.
BACKGROUND AND AIMS: Recent data suggest identification of causal genetic variants for inflammatory bowel disease in the DLG5 gene and in the organic cation transporter (OCTN) cluster, both situated in previously described linkage regions. PATIENTS AND METHODS: The polymorphisms in DLG5 (113 G-->A, 4136 C-->A, and DLG5_e26), SLC22A4 (1672 C-->T), and SLC22A5 (-207 G-->C) were assessed in 625 patients with Crohn's disease (CD), 363 patients with ulcerative colitis (UC), and 1012 healthy controls. Association with disease susceptibility, clinical phenotypes, and possible genetic interactions of these polymorphisms with disease associated CARD15/NOD2 mutations was analysed. RESULTS: No significant association of DLG5 polymorphisms with CD or UC was observed. Homozygosity for the OCTN-TC haplotype was associated with an increased CD risk (OR = 1.65), which was even greater in the presence of CARD15 mutations. Genotype-phenotype analysis revealed that this association was particularly strong in patients with colonic disease. The TC haplotype was associated with non-fistulising non-fibrostenotic disease, an earlier age of disease onset, and reduced need for surgery. CONCLUSION: Our observations argue against a role of DLG5 polymorphisms in the susceptibility for inflammatory bowel disease, whereas the OCTN polymorphisms are associated with CD. However, due to the comparable weak association observed herein, extended linkage disequilibrium analyses of these variants with the IBD5 haplotype tagged single nucleotide polymorphims might be advisable before definitive conclusions about their causative role in CD can be drawn.
Authors: Monika Stoll; Brit Corneliussen; Christine M Costello; Georg H Waetzig; Bjorn Mellgard; W Andreas Koch; Philip Rosenstiel; Mario Albrecht; Peter J P Croucher; Dirk Seegert; Susanna Nikolaus; Jochen Hampe; Thomas Lengauer; Stefan Pierrou; Ulrich R Foelsch; Christopher G Mathew; Maria Lagerstrom-Fermer; Stefan Schreiber Journal: Nat Genet Date: 2004-04-11 Impact factor: 38.330
Authors: Vanya D Peltekova; Richard F Wintle; Laurence A Rubin; Christopher I Amos; Qiqing Huang; Xiangjun Gu; Bill Newman; Mark Van Oene; David Cescon; Gordon Greenberg; Anne M Griffiths; Peter H St George-Hyslop; Katherine A Siminovitch Journal: Nat Genet Date: 2004-04-11 Impact factor: 38.330
Authors: Bill Newman; Xiangjun Gu; Richard Wintle; David Cescon; Mehrdad Yazdanpanah; Xiangdong Liu; Vanya Peltekova; Mark Van Oene; Christopher I Amos; Katherine A Siminovitch Journal: Gastroenterology Date: 2005-02 Impact factor: 22.682
Authors: W Klein; A Tromm; T Griga; C Folwaczny; M Hocke; K Eitner; M Marx; N Duerig; J T Epplen Journal: Scand J Gastroenterol Date: 2003-08 Impact factor: 2.423
Authors: J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran Journal: Am J Hum Genet Date: 1999-03 Impact factor: 11.025
Authors: R S McLeod; A H Steinhart; K A Siminovitch; G R Greenberg; S B Bull; J E Blair; C R Cruz; P M Barton; Z Cohen Journal: Dis Colon Rectum Date: 1997-05 Impact factor: 4.585
Authors: Dermot P B McGovern; David A Van Heel; Kenichi Negoro; Tariq Ahmad; Derek P Jewell Journal: Am J Hum Genet Date: 2003-12 Impact factor: 11.025
Authors: Matthias Jürgens; Stephan Brand; Rüdiger P Laubender; Julia Seiderer; Jürgen Glas; Martin Wetzke; Johanna Wagner; Simone Pfennig; Cornelia Tillack; Florian Beigel; Maria Weidinger; Fabian Schnitzler; Martin E Kreis; Burkhard Göke; Peter Lohse; Karin Herrmann; Thomas Ochsenkühn Journal: J Gastroenterol Date: 2010-04-29 Impact factor: 7.527
Authors: Alexandra V Pearce; Sheila A Fisher; Natalie J Prescott; Clive M Onnie; Reenal Pattni; Peter Green; Alastair Forbes; John Mansfield; Jeremy Sanderson; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew Journal: Int J Colorectal Dis Date: 2006-05-31 Impact factor: 2.571
Authors: Maria Gazouli; Gerassimos Mantzaris; Athanassios J Archimandritis; George Nasioulas; Nicholas P Anagnou Journal: World J Gastroenterol Date: 2005-12-21 Impact factor: 5.742